Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive

Poggi, Alessandro; Varesano, Serena; Zocchi, Maria Raffaella

doi:10.3389/fimmu.2018.01342

CORRECTION article

Front. Immunol. , 11 June 2018

Sec. Cancer Immunity and Immunotherapy

Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.01342

This article is part of the Research Topic Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy View all 15 articles

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive

This article is a correction to:

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
1. Read original article

$\r\nAlessandro Poggi*$ Alessandro Poggi¹*

Serena Varesano¹ $Maria Raffaella Zocchi\r\n$ Maria Raffaella Zocchi²

¹Molecular Oncology and Angiogenesis Unit, Policlinico San Martino, Genoa, Italy
²Division of Immunology, Transplants and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy

A corrigendum on

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
by Poggi A, Varesano S, Zocchi MR. Front Immunol (2018) 9:262. doi: 10.3389/fimmu.2018.00262

There is an error in the Funding statement. The correct name for one of the funders is Ministero della Salute. The correct Funding statement is: This work has been partially supported by grants from AIRC to AP (IG15483) and AIRC to MZ (IG17074) and from 5xmille 2012 Ministero della Salute, 5xmille 2013 Ministero della Salute, 5xmille 2014 Ministero della Salute, and 5xmille 2015 Ministero della Salute to AP. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: mesenchymal stromal cells, carcinoma-associated fibroblast, tumor-associated fibroblast, tumor microenvironment, immunosuppression

Citation: Poggi A, Varesano S and Zocchi MR (2018) Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Front. Immunol. 9:1342. doi: 10.3389/fimmu.2018.01342

Received: 25 May 2018; Accepted: 29 May 2018;
Published: 11 June 2018

Approved by:

Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland

Copyright: © 2018 Poggi, Varesano and Zocchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alessandro Poggi, YWxlc3NhbmRyby5wb2dnaUBoc2FubWFydGluby5pdA==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive

Conflict of Interest Statement

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good